Mechanical Assist Device-Assisted Percutaneous Coronary Intervention: The Use of Impella Versus Extracorporeal Membrane Oxygenation as an Emerging Frontier in Revascularization in Cardiogenic Shock

Researchers conducted a literature analysis to weigh the benefits and risks of using Impella versus ECMO for use in cases of cardiogenic shock. They reviewed each method’s efficacy, clinical outcomes, cost-effectiveness, complications, and limitations. The study found that Impella ranked higher in each of these categories but had inconclusive data on long-term results.